The company expired its plan on March 12, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10 USD | -3.10% |
|
-5.39% | -30.12% |
06-05 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
05-15 | Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.12% | 183M | |
+26.84% | 439B | |
+38.61% | 291B | |
+18.04% | 152B | |
+11.38% | 96.26B | |
+22.49% | 87.42B | |
+66.99% | 62.46B | |
+10.00% | 44.48B | |
+14.04% | 34.15B | |
-15.16% | 30.29B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- OptimizeRx Corporation's Equity Buyback announced on March 14, 2023.has expired with 526,999 shares, representing 3.08% for $7.52 million.